Ampio Pharmaceuticals (NYSE:AMPE) Now Covered by StockNews.com

Equities researchers at StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a report released on Friday. The firm set a “sell” rating on the stock.

Ampio Pharmaceuticals Price Performance

AMPE opened at $0.00 on Friday. The stock has a market capitalization of $2,497.00, a PE ratio of 0.00 and a beta of 3.73. Ampio Pharmaceuticals has a twelve month low of $0.00 and a twelve month high of $7.47.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.